---
document_datetime: 2023-11-15 10:13:35
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/sildenafil-actavis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: sildenafil-actavis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 19.6335023
conversion_datetime: 2025-12-24 15:56:16.864584
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Sildenafil Actavis

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0026               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 10/11/2023                          |                                             | PL                               |           |
| IB/0025/G            | This was an application for a group of variations.                                               | 19/10/2023                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|             | product - Other variation B.II.d.1.h - Change in the specification parameters and/or limits of the finished product - Update of the dossier to comply with the provisions of an updated general monograph of the Ph. Eur. for the finished product                                                                    |            |            |                        |                                                                                                                                                            |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/1612     | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                            | 31/05/2023 | 29/06/2023 | SmPC, Labelling and PL |                                                                                                                                                            |
| IB/0023     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                        | 27/06/2022 | 29/06/2023 | SmPC and PL            | To update section 4.5 of the SmPC to add a warning about the increase in hypotension observed with concomitant use of sildenafil and sacubitril/valsartan. |
| IAIN/0022/G | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.7 - Administrative change - Deletion of manufacturing sites                                                                           | 12/03/2021 | 23/07/2021 | Annex II and PL        |                                                                                                                                                            |
| IA/0021/G   | This was an application for a group of variations. B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.III.1.a.2 - Submission of a new/updated or | 11/03/2021 | n/a        |                        |                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           | relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                            |            |            |                                  |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| IB/0020   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 05/08/2020 | 23/07/2021 | SmPC, Annex II, Labelling and PL |
| N/0019    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 14/11/2018 | 23/07/2021 | PL                               |
| N/0018    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 06/04/2018 | 23/07/2021 | PL                               |
| IB/0017/G | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 06/06/2016 | 22/05/2017 | SmPC, Labelling and PL           |

<div style=\"page-break-after: always\"></div>

| IA/0016   | - Submission of a new/updated or of Ph. Eur. Certificate of Suitability to the Ph. Eur. Monograph - Updated certificate an already approved manufacturer                                                                                                                                                                                                                       | 23/05/2016   | n/a        |                        | B.III.1.a.2 deletion relevant from   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|--------------------------------------|
| IA/0015   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                    | 23/05/2016   | n/a        |                        |                                      |
| IB/0014   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                   | 22/12/2015   | 25/01/2016 | SmPC, Labelling and PL |                                      |
| IB/0013/G | This was an application for a group of variations. B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation | 08/06/2015   | n/a        |                        |                                      |
| IAIN/0012 | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                                                                                                        | 29/05/2015   | n/a        |                        |                                      |

<div style=\"page-break-after: always\"></div>

| R/0010    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 24/07/2014   | 04/09/2014   | SmPC and PL            | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance,                                                                                                                                                                                                       |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0011 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 25/04/2014   | 04/09/2014   | Annex II and PL        |                                                                                                                                                                                                                                                                                                                              |
| IB/0009/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 04/11/2013   | 03/03/2014   | SmPC, Labelling and PL | 1. Harmonisation of the PI in line with the Originator product and update to the latest QRD template vs.9. 2. Update of Section 4.4 of the SmPC to revise the information on acute NAION based on new data coming from the clinical study A1481259 according to the Originator. The package leaflet was amended accordingly. |

<div style=\"page-break-after: always\"></div>

| N/0008   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                               | 01/10/2013   | 03/03/2014   | PL                    | Update of the local representatives contact details and inclusion of an additional local representative of the MAH for the new Member State, Croatia.                                                                                                                                                                                                                                                                                                                       |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0006  | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 20/03/2013   | 03/03/2014   | SmPC, Annex II and PL | Implementation of changes approved in the reference product - update of section 4.8 to add 'Penile haemorrhage, Haematospermia, and Haematuria' with an uncommon frequency and deletion of the footnote referring to ear disorders as requested by CHMP. The Package Leaflet was updated accordingly. The MAH also took the opportunity to make minor linguistic amendments in line with the reference product and to update Annex II according to the latest QRD template. |
| N/0004   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                               | 16/01/2013   | 03/03/2014   | PL                    | Update of the list of local representatives contact details in the package leaflet.                                                                                                                                                                                                                                                                                                                                                                                         |
| IB/0003  | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                                                                 | 23/08/2012   | n/a          |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IB/0002  | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 24/03/2011   | n/a          | SmPC, Annex II and PL | Addition of the adverse drug reactions Stevens Johnsons Syndrome (SJS) AND Toxic Epidermal Necrolysis with unknown frequency in the SmPCs and PLs. The MAH also updated the EMA address in the SmPCs and in the PLs and deleted the DDPS version number in Annex IIB. These changes were made to bring this product information in line with the Originator product information.                                                                                            |
| IA/0001  | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                             | 20/10/2010   | n/a          |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>